Proteinuria in a patient with Graves' disease: Answers

Pediatr Nephrol. 2019 Aug;34(8):1383-1385. doi: 10.1007/s00467-019-04221-x. Epub 2019 Mar 6.
No abstract available

Keywords: Anti-PLA2R; Children; Graves’ disease; Membranous nephropathy; Rituximab.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antithyroid Agents / therapeutic use*
  • Biopsy
  • Diagnosis, Differential
  • Female
  • Glomerular Basement Membrane / pathology
  • Glomerulonephritis, IGA / diagnosis
  • Glomerulonephritis, IGA / etiology
  • Glomerulonephritis, Membranoproliferative / diagnosis
  • Glomerulonephritis, Membranous / diagnosis*
  • Glomerulonephritis, Membranous / drug therapy
  • Glomerulonephritis, Membranous / etiology
  • Glomerulonephritis, Membranous / pathology
  • Graves Disease / complications
  • Graves Disease / diagnosis*
  • Graves Disease / drug therapy
  • Graves Disease / urine
  • Humans
  • Methimazole / therapeutic use
  • Nephrosis, Lipoid / diagnosis
  • Nephrosis, Lipoid / etiology
  • Proteinuria / diagnosis*
  • Proteinuria / drug therapy
  • Proteinuria / etiology
  • Proteinuria / pathology
  • Rituximab / therapeutic use
  • Treatment Outcome

Substances

  • Antithyroid Agents
  • Rituximab
  • Methimazole